Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

July 1, 2025

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

TQH2722 injection

TQH2722 injection is a humanized monoclonal antibody targeting interleukin-4 receptor alpha (IL-4Rα).

DRUG

TQH2722 Placebo

Placebo without drug substance.

Trial Locations (30)

50000

Hebei Medical University Third Hospital, Shijiazhuang

100034

Peking University First Hospital, Beijing

100044

Peking University People's Hospital, Beijing

100191

Peking University Third Hospital, Beijing

110004

Shengjing Hospital of China Medical University, Shenyang

112700

Liaoning Health Industry Group Iron Coal General Hospital, Tieling

114000

Ansteel Group General hospital, Anshan

250000

Shandong Second Provincial General Hospital, Jinan

250012

Qilu Hospital of Shandong University, Qilu

255036

Zibo Central Hospital, Zibo

264000

Yantai Yuhuangding Hospital, Yantai

300041

Tianjin Medical University General Hospital, Tianjin

300121

Tianjin People's Hospital, Tianjin

300192

Tianjin First Central Hospital, Tianjin

430014

The Central Hospital of Wuhan, Wuhan

430022

Union Hospital, Tongji Medical College, Huazhong University of science and technology, Wuhan

430030

Tongji Hospital of Tongji medical college of HUST, Wuhan

430071

Zhongnan Hospital of Wuhan University, Wuhan

450000

Henan Provincial People's Hospital, Zhengzhou

650032

The First Affiliated Hospital of Kunming Medical University, Kunming

710004

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

730000

Gansu Provincial Hospital, Lanzhou

750000

The First People's Hospital of Yinchuan, Yinchuan

830054

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

061017

Cangzhou Central Hospital, Cangzhou

014000

Baotou Central Hospital, Baotou

024005

Chifeng Municipal Hospital, Chifeng

015000

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

030000

Shanxi Bethune Hospital, Taiyuan

All Listed Sponsors
lead

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

INDUSTRY

NCT06760182 - Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter